Under the insightful leadership of executives like Raje, LGM Pharma has experienced significant evolution since being acquired by New Harbour Capital Private Equity. Initially, LGM Pharma was primarily focused on supply chain logistics within the pharmaceutical industry. However, it has since
Ireland's biopharmaceutical industry is on the verge of substantial expansion, with an expected increase of 21,000 jobs by 2027. The Expert Group on Future Skills Needs (EGFSN) has highlighted the essential role of the biopharma sector in bolstering the national economy. Despite the optimistic job
As environmental issues become ever more pressing, pharmaceutical giant Boehringer Ingelheim is leading a green revolution within its industry, with a special focus on sustainable vaccine production. The company's innovative initiatives extend well beyond the finished vaccine. Boehringer
The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical
Upstream bioprocessing is pivotal in biomanufacturing, where cellular systems produce vital therapeutic proteins and biological products. This field is experiencing a surge of innovative methods in response to the increased global demand for biopharmaceuticals driven by rising health concerns.
Lantern Pharma's LP-300 signals a significant advancement in the fight against non-small cell lung cancer (NSCLC), particularly in never-smokers—a group seeing elevated incidence rates, notably in East Asia. This promising therapeutic option stands out as NSCLC treatments often overlook the unique
